AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 46 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 99 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 99 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 99 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 99 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 99 | -98.5% | 0.00% | – |
| Q1 2022 | $16,000 | -96.6% | 6,660 | -93.2% | 0.00% | – |
| Q4 2021 | $466,000 | +255.7% | 98,306 | +494.9% | 0.00% | – |
| Q3 2021 | $131,000 | +227.5% | 16,524 | +191.5% | 0.00% | – |
| Q2 2021 | $40,000 | -86.7% | 5,668 | -85.1% | 0.00% | – |
| Q1 2021 | $301,000 | +159.5% | 37,962 | +157.9% | 0.00% | – |
| Q4 2020 | $116,000 | -16.5% | 14,720 | -25.0% | 0.00% | – |
| Q3 2020 | $139,000 | -34.7% | 19,636 | -15.1% | 0.00% | – |
| Q2 2020 | $213,000 | +419.5% | 23,137 | +166.7% | 0.00% | – |
| Q1 2020 | $41,000 | -79.7% | 8,675 | -67.2% | 0.00% | – |
| Q4 2019 | $202,000 | +92.4% | 26,481 | +94.3% | 0.00% | – |
| Q3 2019 | $105,000 | -11.0% | 13,627 | -20.8% | 0.00% | – |
| Q2 2019 | $118,000 | +18.0% | 17,198 | +37.9% | 0.00% | – |
| Q1 2019 | $100,000 | +69.5% | 12,472 | +104.0% | 0.00% | – |
| Q3 2018 | $59,000 | +353.8% | 6,113 | +411.1% | 0.00% | – |
| Q2 2018 | $13,000 | -59.4% | 1,196 | -62.6% | 0.00% | – |
| Q1 2018 | $32,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 20,592 | $347,798 | 24.67% |
| VR Adviser, LLC | 295,034 | $3,614,167 | 0.38% |
| IFP Advisors, Inc | 2,860 | $1,718 | 0.00% |